The Pharmintech related industries, together with the industries upstream of pharmaceutical production, consolidate the recovery and look forward to the first half of 2012 with good prospects. The indication comes from the survey by the Observatory which supports the Pharmintech international fair, which brings together Italian companies operating in the sectors of machinery, materials and services for the pharmaceutical industry. A third of the companies in the survey sample report growing turnover in the second half of 2011: for almost 50% it is unchanged and only 19% indicates a decrease in total turnover. The distribution for exports is almost similar, with a slight shift in the percentage share from an increase (29%) towards stability (57%) while only 14% indicates a reduction. For the first half of 2012, the 36% of the sample predicts an increase in turnover, while those who assume a reduction stop at 15%. Positive expectations that are also reflected in theexport, with a positive balance between companies expecting an increase in foreign turnover (31% of the total) and those expecting a reduction (12). Positive notes also on the employment side: stability for over 3/4 of the companies, with the remaining share presenting a positive balance between companies. "The drug supply chain is an important supply chain" - declared Massimo Scaccabarozzi, President of Farmindustria - "and decisive for the Italian economy, it has, in fact, 67,000 employees and another 64,000 is related to it with a wage bill of 4.5 billion and a total production of 36 billion".
(Il Sole 24 Ore – Special Page 25 – 03/04/2012)
